Business
OTC Markets Group Welcomes New OTCQB Companies – July 17
OTC Markets Group Welcomes New OTCQB Companies – July 17.
About this update from Idw Media Holdings, Inc.
[{"type":"text","content":"OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, announced the following companies are approved for trading on the OTCQB Venture Market:Caravan Energy Corporation (CSE: CNRG; OTCQB: CENCF) Caravan Energy Corporation is a Canadian exploration company. The Company is currently focused on the exploration of the EBB Nickel-Cobalt property. The property comprises three contiguous mining claims covering approximately 2,199.74 hectares near Port Renfrew, BC.HERTZ LITHIUM INC. (CSE: HZ; OTCQB: HZLIF) Developing Hard Rock Lithium Along The Arizona Pegmatite BeltIDW Media Holdings, Inc. (OTCQB: IDWM) IDW Media Holdings, Inc is a diversified media company with operations in publishing and television entertainment. Its principal businesses include: (1) IDW Publishing (\"IDWP\"), which creates comic books, graphic novels and digital content through its imprints IDW, Top Shelf Productions and Artist's Editions; and (2) IDW Entertainment, which is a production company and studio that develops, produces and distributes content based on IDWP's original, copyrighted intellectual property, published in the form of comic books, graphic novels and any other forms of print publication, for a variety of formats including film and television. Lumina Gold Corp (TSX-V: LUM; OTCQB: LMGDF) Lumina Gold Corp is a Vancouver, Canada based precious and base metals exploration and development company focused on its Cangrejos Gold-Copper project, located in El Oro Province, southwest Ecuador. Cangrejos has a 26 year mine life, producing ~370koz of gold per year / ~40Mlbs of copper per year and is being advanced to a Feasibility study. The Company has an experienced management team with a successful track record of advancing and monetizing exploration projects.MARVEL BIOSCIENCES CORP. (TSX-V: MRVL; OTCQB: MBCOF) Marvel Biosciences Corp is a life sciences company focused on the discovery and the development of a synthetic derivative compound of a known proven drug. It has developed several new patented and patentable chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression and anxiety, Alzheimer's, ADHD and addiction), cancer, and application to the non-neurological dis...